Assertio Therapeutics Stock Market Value
| ASRT Stock | USD 0.67 0.01 1.47% |
| Symbol | Assertio |
Assertio Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets |
The market value of Assertio Therapeutics is measured differently than its book value, which is the value of Assertio that is recorded on the company's balance sheet. Investors also form their own opinion of Assertio Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Assertio Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assertio Therapeutics' market value can be influenced by many factors that don't directly affect Assertio Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assertio Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assertio Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assertio Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assertio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assertio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assertio Therapeutics.
| 04/21/2025 |
| 07/20/2025 |
If you would invest 0.00 in Assertio Therapeutics on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding Assertio Therapeutics or generate 0.0% return on investment in Assertio Therapeutics over 90 days. Assertio Therapeutics is related to or competes with Aquestive Therapeutics, Dynavax Technologies, Amphastar, Lantheus Holdings, ANI Pharmaceuticals, Grace Therapeutics,, and Citius Pharmaceuticals. Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and... More
Assertio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assertio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assertio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.07 | |||
| Information Ratio | 0.0048 | |||
| Maximum Drawdown | 12.61 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 4.92 |
Assertio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assertio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assertio Therapeutics' standard deviation. In reality, there are many statistical measures that can use Assertio Therapeutics historical prices to predict the future Assertio Therapeutics' volatility.| Risk Adjusted Performance | 0.0594 | |||
| Jensen Alpha | 0.0394 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0043 | |||
| Treynor Ratio | 0.18 |
Assertio Therapeutics Backtested Returns
Assertio Therapeutics appears to be very risky, given 3 months investment horizon. Assertio Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0875, which signifies that the company had a 0.0875 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Assertio Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Assertio Therapeutics' Risk Adjusted Performance of 0.0594, downside deviation of 3.07, and Mean Deviation of 2.07 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Assertio Therapeutics holds a performance score of 6. The firm shows a Beta (market volatility) of 0.8, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Assertio Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Assertio Therapeutics is expected to be smaller as well. Please check Assertio Therapeutics' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Assertio Therapeutics' price patterns will revert.
Auto-correlation | 0.68 |
Good predictability
Assertio Therapeutics has good predictability. Overlapping area represents the amount of predictability between Assertio Therapeutics time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assertio Therapeutics price movement. The serial correlation of 0.68 indicates that around 68.0% of current Assertio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Assertio Therapeutics lagged returns against current returns
Autocorrelation, which is Assertio Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Assertio Therapeutics' stock expected returns. We can calculate the autocorrelation of Assertio Therapeutics returns to help us make a trade decision. For example, suppose you find that Assertio Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Assertio Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Assertio Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Assertio Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Assertio Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Assertio Therapeutics Lagged Returns
When evaluating Assertio Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Assertio Therapeutics stock have on its future price. Assertio Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Assertio Therapeutics autocorrelation shows the relationship between Assertio Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Assertio Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.